Sectra and Synthetic MR extend cooperation through distribution agreement

Sectra and Synthetic MR extend cooperation through distribution agreement		

The IT and medical company Sectra and Synthetic MR AB, which develops analysis
and imaging methods based on synthetic MRI (Magnet Resonance Imaging), have
signed a distribution agreement for Synthetic MR AB's software-based technology
for significantly improved patient flow and analysis of MR examinations.

In accordance with the agreement, Sectra will distribute Synthetic MR's
software, SyMRI Suite, as a plug-in in its PACS system (Picture Archiving
Communication System).

“With Synthetic MR's software as part of our PACS system, we will significantly
increase not only the efficiency of the actual MR examinations, but also the
effectiveness of the radiologists, through enhanced possibilities for
identifying pathological tissue,” says Torbjörn Kronander, President of Sectra's
medical business. “The agreement with SyntheticMR strengthens Sectra's offering
in MR and gives us an advantage in a rapidly expanding market.”

“As a result of the distribution agreement, we are deepening the cooperation
that we initiated with Sectra nearly a year ago,” says Marcel Warntjes,
President of SyntheticMR. “Sectra is world-leading in its area and I am very
pleased that we will gain access in this manner to Sectra's network, marketing
and sales team. For SyntheticMR, the agreement is an important step in our
commercialization process.” 


Dr. Torbjörn Kronander, President, Sectra Imtec AB, +46 705 23 52 27 
Dr. Jan-Olof Brüer, CEO and President, Sectra AB, +46 13 23 52 09
Dr. Marcel Warntjes, CEO Synthetic MR  AB, tel. +46 730 738544
Andreas Bunge, CEO Accelerator Nordic AB, tel. +46 8 663 57 16


About Sectra's medical operations
Sectra develops and sells IT-systems and products for radiology, mammography and
orthopedic departments. More than 1,000 hospitals worldwide use the system
daily, together performing over 45 million radiology examinations annually. This
makes Sectra one of the world leading companies within systems for handling
digital radiology images (PACS). In Scandinavia, Sectra is the market leader
with more than 50% of all film-free installations. Outside Scandinavia, Sectra's
system is installed at customers in North America and most major countries in
Europe and the Far East.

About the Sectra Group
Sectra successfully develops and sells cutting-edge products in the expansive
niche segments of medical systems and secure communication systems.  The company
was founded in 1978 and has its roots in the Linköping Institute of Technology
in Sweden.  Today, Sectra has offices in eleven countries and operates through
partners worldwide. Sales in the 2007/2008 fiscal year totaled SEK 743 million.
The Sectra share is quoted on the NASDAQ OMX Stockholm AB exchange. For more
information, visit www.sectra.com.

About SyntheticMR AB
SyntheticMR AB is a member of the Accelerator Nordic Group. Synthetic Magnetic
Resonance Imaging is a technology for MR examinations that, by using the SyMRI
Suite software, drastically reduces the time required for MR examinations and
supports diagnosis with quantitative images. The SyMRI Suite can be integrated
with MR software and such follow-up systems as PACS and can increase the
efficiency of existing systems and work flows and ensure more rapid and
quantitative follow-up of treatment, shorter waiting times and potential
reduction in care times. For further information, visit our website: 
http://www.syntheticmr.se/

About Accelerator Nordic AB
Accelerator Nordic AB is a group with active ownership in a number of
development-intensive Swedish companies in biopharma and medical technology. In
biopharma, there are the subsidiaries PledPharma AB, which develops
pharmaceuticals based on clinically approved PLED derivatives, Spago Imaging AB,
which develops nano-particle-based contrast medium for diagnostic imaging,
AddBIO AB, which develops technology for the delivery of pharmaceuticals from
implants, and Optovent AB, which refines and commercializes research-based
innovations in drug delivery. In medical technology, operations are conducted by
the companies SyntheticMR AB, which develops analysis and imaging methods for
synthetic magnetic resonance, and OptoQ AB, which markets and sells systems and
technology platforms for secure and cost-efficient patient-monitoring.
Accelerator Nordic AB is listed on the Aktietorget exchange in Stockholm,
Sweden.
For further information, visit: www.acceleratorab.se